Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9849
Full metadata record
DC FieldValueLanguage
dc.contributor.authorErkuran, H.O.-
dc.contributor.authorÇakaloz, Burcu-
dc.contributor.authorOnen, O.-
dc.contributor.authorKutlu, A.-
dc.date.accessioned2019-08-16T13:06:47Z-
dc.date.available2019-08-16T13:06:47Z-
dc.date.issued2016-
dc.identifier.issn1017-7833-
dc.identifier.urihttps://hdl.handle.net/11499/9849-
dc.identifier.urihttps://doi.org/10.5455/bcp.20151223093022-
dc.description.abstractAttention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodevelopmental disorders in childhood with its reported worldwide prevalance as 5%. Among the recommended treatment regimens as stimulants, the most frequently advised ones are methylphenidate (MPH) preparates. Among long acting MPH preparates, the form that contains an osmotic release oral system (MPH-OROS) is frequently used in clinical practice. Studies about risks, causes and outcomes regarding high dose MPH intake and effects of high dose MPH preparates in humans are limited. This article presents the clinical picture of a 12 year old boy who attempted suicide by ingesting 15 tablets of 36-mg MPH OROS. Exposure to an overdose of MPH-OROS exhibited acute sympathomimetic toxicity but no life-threatening symptoms in this patient. This case report might suggest that higher doses of MPH-OROS could be tolerated well under fine clinical observation and management; although more larger scale studies in this field would be required. © 2016, Cukurova Univ Tip Fakultesi Psikiyatri Anabilim Dali. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherCukurova Univ Tip Fakultesi Psikiyatri Anabilim Dalien_US
dc.relation.ispartofKlinik Psikofarmakoloji Bultenien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDrug safetyen_US
dc.subjectIntoxicationen_US
dc.subjectLong acting methylphenidateen_US
dc.subjectMPH OROSen_US
dc.subjectSuicideen_US
dc.subjectactivated carbonen_US
dc.subjectmethylphenidateen_US
dc.subjectangeren_US
dc.subjectArticleen_US
dc.subjectblood pressureen_US
dc.subjectbody temperatureen_US
dc.subjectcase reporten_US
dc.subjectchilden_US
dc.subjectconflicten_US
dc.subjectdisorientationen_US
dc.subjectgustatory hallucinationen_US
dc.subjectheart rateen_US
dc.subjecthumanen_US
dc.subjectmaleen_US
dc.subjectschool childen_US
dc.subjectsuicide attempten_US
dc.subjectvisual hallucinationen_US
dc.titleSuicide attempt with high dose long acting methylphenidate ingestion: A case presentationen_US
dc.typeArticleen_US
dc.identifier.volume26en_US
dc.identifier.issue3en_US
dc.identifier.startpage316en_US
dc.identifier.endpage318en_US
dc.identifier.doi10.5455/bcp.20151223093022-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-84987643822en_US
dc.identifier.trdizinid204245en_US
dc.identifier.wosWOS:000385785800014en_US
dc.identifier.scopusqualityQ3-
dc.ownerPamukkale University-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File SizeFormat 
10.5455 bcp.20151223093022.pdf393 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

4
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

3
checked on Jul 10, 2024

Page view(s)

56
checked on May 27, 2024

Download(s)

20
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.